Journal profile · OPHTHALMOLOGY

Ophthalmologie

ISSN 2731-720X · eISSN 2731-7218 · Springer Nature

Ophthalmologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.59; hybrid open access; APC about USD 3,390; median 84 days to acceptance (78 articles, last 24 months); 204 articles in 2025; indexed in SCIE and Scopus.

Impact factor0.59Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time84 daysMedian, submission to acceptance · 78 articles, last 24 months · Crossref
APCUSD 3,390Hybrid journal: charged only for open-access articles
Acceptance—No reports yet
Articles per year2042025 · OpenAlex count

Scope

Aims, scope and focus

Ophthalmologie is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Corneal surgery and disorders and Intraocular Surgery and Lenses, together about 25.9% of its articles. Its main subfields are Ophthalmology and Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): OPHTHALMOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Glaucoma and retinal disordersMedicine11.1%
  2. Corneal surgery and disordersMedicine8.3%
  3. Intraocular Surgery and LensesMedicine6.5%
  4. Retinal and Macular SurgeryMedicine6.3%
  5. Retinal Diseases and TreatmentsMedicine6.2%
  6. Ocular Diseases and Behçet’s SyndromeMedicine6.1%
  7. Ophthalmology and Visual Impairment StudiesMedicine5.9%
  8. Ocular Oncology and TreatmentsMedicine5.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOphthalmologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOphthalmologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOphthalmologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0.59LetPub ·
CiteScore 2026-06
1.2LetPub ·
SJR 2026-06
0.26LetPub ·
SNIP 2026-06
0.32LetPub ·
h-index
10OpenAlex ·
i10-index
12OpenAlex ·
2-year mean citedness
0.52OpenAlex ·
Self-citation rate
16.7%LetPub ·
Share of gold OA articles
41.88%LetPub ·

Volume

Articles per year
117LetPub ·

Articles by year OpenAlex count · 973 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261638119
20252049863
2024192113207
202317791290
2022195126374
2021413149

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

84 daysMedian, submission to acceptance · P25–P75 56 days – 114 days

Acceptance to online
median 31 days (105 articles)
Submission to online
median 118 days
Sample
78 articles with submission and acceptance dates (409 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,390 / EUR 2,790 / GBP 2,390——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Springer Nature
ISSN
2731-720X
Electronic ISSN
2731-7218

FAQ

Frequently asked questions about Ophthalmologie

What CAS zone is Ophthalmologie in?

In the 2025 upgraded edition of the CAS Journal Ranking, Ophthalmologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Ophthalmologie?

The latest impact factor listed by LetPub is 0.59; CiteScore 1.2, h-index 10.

How long does peer review take at Ophthalmologie?

Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 56–114 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Ophthalmologie?

According to LetPub and DOAJ records, Ophthalmologie is indexed in SCIE and Scopus.

Is Ophthalmologie open access, and what is the APC?

Ophthalmologie is a hybrid journal. For open-access publication: APC about USD 3,390.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .